ZENITHDRUG — Zenith Drugs Share Price
Last trade - 00:00- IN₹1.34bn
- IN₹1.72bn
- IN₹1.32bn
- 13
- 40
- 50
- 23
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.06 | ||
| Price to Tang. Book | 2.06 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.08 | ||
| EV to EBITDA | 14.15 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.45% | ||
| Return on Equity | 21.87% | ||
| Operating Margin | 8.68% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | 916.55 | 1,145.19 | 1,316.2 | n/a | n/a | 19.83% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +56.01 | +94.21 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zenith Drugs Ltd is an India-based pharmaceutical company. The Company is mainly engaged in the business of manufacturing and trading of medicine. The Company offers a range of formulations in various forms, such as ORS powder, liquid oral, ointments, creams, gels and liquid externals, capsules, tablets. Its liquid oral products include Aceclofenac & Paracetamol Suspension; Albendazole Oral Suspension BP 25 mg/ml; Ambroxol Hydrochloride & Levocetirizine Dihydrochloride Syrup; Bromhexine Hydrochloride Syrup 4mg/5ml; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Chlorphenamine, Ammonium Chloride and Sodium Citrate Syrup; Chlorpheniramine Maleate Oral Solution USP 2 mg / 5 ml, and others. Its ointment products include Cetrimide Cream BP 0.5% w/w, Chloroxylenol Cream 0.8% w/w, Ciprofloxacin Cream 0.5% w/w, Ciprofloxacin with Fluocinolone & Clotrimazole Cream and others.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- November 15th, 2000
- Public Since
- February 27th, 2024
- No. of Employees
- 126
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 17,148,800
- Address
- K No 72/5 Village Muradpura Depalpur, INDORE, 453001
- Web
- https://www.zenithdrugs.com/
- Phone
- Auditors
- VD S & Company
Similar to ZENITHDRUG
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 24:14 UTC, shares in Zenith Drugs are trading at IN₹81.80. This share price information is delayed by 15 minutes.
Shares in Zenith Drugs last closed at IN₹81.80 and the price had moved by +27.51% over the past 365 days. In terms of relative price strength the Zenith Drugs share price has outperformed the S&P BSE 100 Index by +20.12% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Zenith Drugs dividend yield is 0.61% based on the trailing twelve month period.
Last year, Zenith Drugs paid a total dividend of IN₹0.50, and it currently has a trailing dividend yield of 0.61%. We do not have any data on when Zenith Drugs is to next pay dividends.
We do not have data on when Zenith Drugs is to next pay dividends. The historic dividend yield on Zenith Drugs shares is currently 0.61%.
To buy shares in Zenith Drugs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹81.80, shares in Zenith Drugs had a market capitalisation of IN₹1.34bn.
Here are the trading details for Zenith Drugs:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ZENITHDRUG
Based on an overall assessment of its quality, value and momentum Zenith Drugs is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zenith Drugs. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -13.93%.
As of the last closing price of IN₹81.80, shares in Zenith Drugs were trading -9.84% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Zenith Drugs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹81.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Zenith Drugs' directors